Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients

NCT02022995 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02022995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02022995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
January 31, 2016
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer adenocarcinoma